Part three summarizes activities relating to the status and development of biological reference materials for various antibodies, antibiotics, blood products and related substances, cytokines and growth factors, and other substances.The fourth and most extensive part issues detailed guidelines for the production and control of synthetic peptide vaccines, requirements for tick-borne encephalitis va